%0 Journal Article %T Delirium in the US: Results from 2023 cross-sectional World Delirium Awareness Day prevalence study. %A Lindroth H %A Byrnes T %A Fuchita M %A Hetland B %A Liu K %A Maya K %A McAndrew NS %A Mulkey MA %A Nydahl P %A Palakshappa J %A von Haken R %A Psoter KJ %A Oh ES %A %J J Acad Consult Liaison Psychiatry %V 0 %N 0 %D 2024 Jun 27 %M 38944277 暂无%R 10.1016/j.jaclp.2024.06.005 %X OBJECTIVE: Delirium is an acute brain dysfunction associated with an increased risk of mortality and future dementia.
OBJECTIVE: To describe the prevalence of clinically documented delirium in the United States on World Delirium Awareness Day 2023.
METHODS: Sub-analysis of a prospective, cross-sectional, online, international survey.
METHODS: All healthcare settings were eligible with the exception of operating rooms and outpatient clinics.
METHODS: Healthcare clinicians, administrators, and researchers completed the survey.
METHODS: Prevalence of clinically documented delirium at 8:00 a.m. and 8:00 p.m. on March 15, 2023. Secondary outcomes were related to healthcare delivery. Descriptive statistics are reported. Differences between unit types (non-ICU vs ICU) were examined for all outcomes.
RESULTS: Ninety-one hospital units reported on 1,318/1,213 patients. The prevalence of clinically documented delirium was 16.4% (n=216/1,318) at 8:00 a.m., 17.9% (n=217/1,213) at 8:00 p.m. (p= 0.316) and significantly differed between age groups, reported discipline, unit, and hospital types. Significant differences were identified between non-ICU and ICU settings in the use of delirium-related protocols, non-pharmacologic and pharmacologic management, educational processes, and barriers to evidence-based delirium care.
CONCLUSIONS: To our knowledge, this is the first epidemiologic survey of clinically documented delirium across two time points in the U.S.. Delirium remains a significant burden and challenge for healthcare systems. The high percentage of units using delirium management protocols suggests administrator and clinician awareness of evidence-based strategies for its detection and mitigation. We provide recommendations for future studies and quality improvement projects to improve clinical recognition and management of delirium.